摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1-甲基肼)- 嘧啶 | 435337-82-9

中文名称
2-(1-甲基肼)- 嘧啶
中文别名
2-(1-甲基肼)-嘧啶
英文名称
1-methyl-1-pyrimidin-2-yl-hydrazine
英文别名
2-(1-Methylhydrazinyl)pyrimidine;1-methyl-1-pyrimidin-2-ylhydrazine
2-(1-甲基肼)- 嘧啶化学式
CAS
435337-82-9
化学式
C5H8N4
mdl
——
分子量
124.145
InChiKey
GMULQEPLDSVNMR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    55
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:7756cbb74adc0ea2baaa851df66d558d
查看

反应信息

  • 作为反应物:
    描述:
    2-(1-甲基肼)- 嘧啶caesium carbonate三乙胺 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 14.0h, 生成 6-chloro-2-((2-methyl-2-(pyrimidin-2-yl)hydrazineyl)methyl)imidazo[1,2-a]pyridine
    参考文献:
    名称:
    PRMT5 INHIBITORS AND USES THEREOF
    摘要:
    The present disclosure relates generally to compounds that inhibit PRMT5. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through inhibiting PRMT5. The disclosure further relates to the use of the compounds for the treatment of a disease or condition associated with chromosome 9p21 deletion or MTAP null. The disclosure further relates to the use of the compounds for the treatment of cancers.
    公开号:
    WO2024137852A1
  • 作为产物:
    描述:
    2-氯嘧啶甲基肼potassium carbonate 作用下, 以 乙醇 为溶剂, 反应 18.0h, 生成 2-(1-甲基肼)- 嘧啶
    参考文献:
    名称:
    N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES
    摘要:
    提供了一种用于控制环境中内外寄生虫的新型N-苯基-1,1,1-三氟甲磺酰胺化合物,以及制备这些化合物的方法,以及利用这些创新化合物治疗体内和体外寄生虫感染的方法。
    公开号:
    US20070238700A1
点击查看最新优质反应信息

文献信息

  • Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
    申请人:Dow AgroSciences LLC
    公开号:US20180279612A1
    公开(公告)日:2018-10-04
    This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).
    这份披露涉及具有对节肢动物门、软体动物门和线虫门害虫具有杀虫效用的分子领域,用于生产此类分子的过程,用于此类过程的中间体,含有此类分子的杀虫组合物,以及使用此类杀虫组合物对抗此类害虫的过程。这些杀虫组合物可以用作螨虫剂、杀虫剂、螨虫剂、软体动物杀虫剂和线虫杀虫剂。本文件披露了具有以下式(“式一”)的分子。
  • N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES
    申请人:Winzenberg Norman Kevin
    公开号:US20070238700A1
    公开(公告)日:2007-10-11
    Novel N-phenyl-1,1,1-trifluoromethanesulfonamide compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo and ex vivo.
    提供了一种用于控制环境中内外寄生虫的新型N-苯基-1,1,1-三氟甲磺酰胺化合物,以及制备这些化合物的方法,以及利用这些创新化合物治疗体内和体外寄生虫感染的方法。
  • PRMT5 INHIBITORS AND USES THEREOF
    申请人:[en]GILEAD SCIENCES, INC.
    公开号:WO2024137852A1
    公开(公告)日:2024-06-27
    The present disclosure relates generally to compounds that inhibit PRMT5. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through inhibiting PRMT5. The disclosure further relates to the use of the compounds for the treatment of a disease or condition associated with chromosome 9p21 deletion or MTAP null. The disclosure further relates to the use of the compounds for the treatment of cancers.
查看更多